Allen Poirson - 20 May 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Signature
/s/ Valerie Barnett, Attorney-in-Fact
Issuer symbol
CTKB
Transactions as of
20 May 2024
Net transactions value
-$8,624
Form type
4
Filing time
22 May 2024, 18:41:15 UTC
Previous filing
13 Mar 2024
Next filing
21 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise +790 +1.5% 52,195 20 May 2024 Direct F1, F2
transaction CTKB Common Stock Tax liability $1,836 -308 -0.59% $5.96 51,887 20 May 2024 Direct F3
transaction CTKB Common Stock Options Exercise +1,669 +3.2% 53,556 20 May 2024 Direct F1
transaction CTKB Common Stock Tax liability $3,880 -651 -1.2% $5.96 52,905 20 May 2024 Direct F3
transaction CTKB Common Stock Options Exercise +1,252 +2.4% 54,157 20 May 2024 Direct F1
transaction CTKB Common Stock Tax liability $2,908 -488 -0.9% $5.96 53,669 20 May 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Options Exercise $0 -790 -13% $0.000000 5,273 20 May 2024 Common Stock 790 Direct F1, F4
transaction CTKB Restricted Stock Units Options Exercise $0 -1,669 -5.6% $0.000000 28,374 20 May 2024 Common Stock 1,669 Direct F1, F5
transaction CTKB Restricted Stock Units Options Exercise $0 -1,252 -4.2% $0.000000 28,804 20 May 2024 Common Stock 1,252 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 Includes 350 shares acquired by the Reporting Person under the Issuer's 2021 Employee Stock Purchase Plan on November 30, 2023.
F3 Represents the number of shares withheld by and surrendered to the Issuer on May 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
F4 The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
F5 The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.
F6 The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.